The International Vaccine Institute (IVI) hosted the 2022 Award Ceremony of the IVI-SK bioscience P...

SK bioscience is stepping up work on a nasal spray to prevent and treat COVID-19. With the Bill &am...

With its COVID-19 vaccine development project nearing the finish line, SK Bioscience unveils an amb...

The following is a summary of some recent studies on COVID-19. They include research that warrants ...

SEOUL, March 21 (Reuters) - South Korea has reached a deal to buy 10 million doses of the country&a...

SK Bioscience Ltd. is developing a vaccine intended to simultaneously immunize people against the f...

SK Bioscience rolled out the first batch of Nuvaxovid, Novavax’s synthetic antigen-based COVID-19 v...

While the last two years have seen the successful development of COVID-19 vaccines, the emergence ...

The Korean drug regulator is set to approve the use of a COVID-19 vaccine developed by U.S. drugmak...